Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Abernethy

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Rhode Island Medicine|May 1, 1993
Antihypertensive therapy: a look aheadD R Abernethy
The Journal of Clinical Investigation|May 15, 1997
Grapefruits and drugs: when is statistically significant clinically significant?D R Abernethy
Journal of Cardiovascular Pharmacology|January 1, 1991
Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonistD R Abernethy
American Heart Journal|November 1, 1989
The pharmacokinetic profile of amlodipineD R Abernethy
Clinical Pharmacology and Therapeutics|October 23, 2014
Application of systems pharmacology to explore mechanisms of hepatotoxicityJ Shon, D R Abernethy
Journal of the American Geriatrics Society|October 1, 1984
Age effects on alpha-1-acid glycoprotein concentration and imipramine plasma protein bindingD R Abernethy, L Kerzner
Clinical Pharmacology and Therapeutics|July 25, 2014
Use of internet search logs to evaluate potential drug adverse eventsS Sarntivijai, D R Abernethy
Journal of Clinical Pharmacology|November 1, 1983
Ibuprofen does not impair antipyrine clearanceD R Abernethy, D J Greenblatt
The American Journal of the Medical Sciences|September 1, 1993
Effect of calcium antagonists on RNA synthesis of NIH 3T3 cellsN S Andrawis, D R Abernethy
Biochemical Pharmacology|June 1, 1991
Structure-activity relationship of ligands of human plasma adenosine deaminase2J G Niedzwicki, D R Abernethy
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Rhode Island Medicine|May 1, 1993
Antihypertensive therapy: a look aheadD R Abernethy
The Journal of Clinical Investigation|May 15, 1997
Grapefruits and drugs: when is statistically significant clinically significant?D R Abernethy
Journal of Cardiovascular Pharmacology|January 1, 1991
Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonistD R Abernethy
American Heart Journal|November 1, 1989
The pharmacokinetic profile of amlodipineD R Abernethy
Clinical Pharmacology and Therapeutics|October 23, 2014
Application of systems pharmacology to explore mechanisms of hepatotoxicityJ Shon, D R Abernethy
Journal of the American Geriatrics Society|October 1, 1984
Age effects on alpha-1-acid glycoprotein concentration and imipramine plasma protein bindingD R Abernethy, L Kerzner
Clinical Pharmacology and Therapeutics|July 25, 2014
Use of internet search logs to evaluate potential drug adverse eventsS Sarntivijai, D R Abernethy
Journal of Clinical Pharmacology|November 1, 1983
Ibuprofen does not impair antipyrine clearanceD R Abernethy, D J Greenblatt
The American Journal of the Medical Sciences|September 1, 1993
Effect of calcium antagonists on RNA synthesis of NIH 3T3 cellsN S Andrawis, D R Abernethy
Biochemical Pharmacology|June 1, 1991
Structure-activity relationship of ligands of human plasma adenosine deaminase2J G Niedzwicki, D R Abernethy
Pageof 23